Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain.
Tabuenca Del Barrio L, Nova-Camacho LM, Zubicoa Enériz A, Martínez de Espronceda Ezquerro I, Córdoba Iturriagagoitia A, Borque Rodríguez-Maimón E, García-Layana A. Tabuenca Del Barrio L, et al. Among authors: cordoba iturriagagoitia a. Cancers (Basel). 2021 Oct 25;13(21):5347. doi: 10.3390/cancers13215347. Cancers (Basel). 2021. PMID: 34771510 Free PMC article.
Correction to: Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non‑sentinel node status: retrospective cohort study with long follow‑up in a Spanish population.
Loidi-Pascual L, Librero J, Córdoba-Iturriagagoitia A, Guarch-Troyas R, Montes-Díaz M, Ruiz de Azua-Ciria Y, Arozarena I, Goñi-Gironés E, Yanguas I. Loidi-Pascual L, et al. Among authors: cordoba iturriagagoitia a. Arch Dermatol Res. 2022 May;314(4):379. doi: 10.1007/s00403-021-02302-2. Arch Dermatol Res. 2022. PMID: 34812922 No abstract available.
Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population.
Loidi-Pascual L, Librero J, Córdoba-Iturriagagoitia A, Guarch-Troyas R, Montes-Díaz M, Ruiz de Azua-Ciria Y, Arozarena I, Goñi-Gironés E, Yanguas I. Loidi-Pascual L, et al. Among authors: cordoba iturriagagoitia a. Arch Dermatol Res. 2022 May;314(4):369-378. doi: 10.1007/s00403-021-02232-z. Epub 2021 May 10. Arch Dermatol Res. 2022. PMID: 33973061
[Cutaneous CD8+ T-cell lymphoma. Regression after HIV antiviral triple therapy].
Santesteban Muruzábal R, Mitxelena Ezeiza J, Córdoba Iturriagagoitia A, Yanguas Bayona I. Santesteban Muruzábal R, et al. Among authors: cordoba iturriagagoitia a. Med Clin (Barc). 2015 Dec 7;145(11):e33-4. doi: 10.1016/j.medcli.2015.02.017. Epub 2015 Apr 9. Med Clin (Barc). 2015. PMID: 25865613 Spanish. No abstract available.
[Adenoid cystic carcinoma of the breast, 22 years of experience].
Fernández de Los Reyes I, Córdoba Iturriagagoitia A, Chouza Sanin M, Aguiar Losada B, Larrea Ramirez A, Ruíz de Azúa Ciria Y. Fernández de Los Reyes I, et al. Among authors: cordoba iturriagagoitia a. Rev Esp Patol. 2020 Oct-Dec;53(4):206-212. doi: 10.1016/j.patol.2020.06.003. Epub 2020 Jul 24. Rev Esp Patol. 2020. PMID: 33012489 Spanish.
[No title available]
[No authors listed] [No authors listed] PMID: 35132276
[Small cell carcinoma of the bladder. Report of a new case].
Ripa Saldías L, Delpón Pérez E, Fernández Rosaenz J, Córdoba Iturriagagoitia A, Monzón Muñoz FJ, Ruiz de Azua Ciria Y. Ripa Saldías L, et al. Among authors: cordoba iturriagagoitia a. Actas Urol Esp. 1997 May;21(5):495-500. Actas Urol Esp. 1997. PMID: 9412178 Spanish.
36 results